SBIR Topic 131: Development of Bacteriophage for Treatment of Mycobacterial Infections

NIH RePORTER · NIH · N43 · $297,740 · view on reporter.nih.gov ↗

Abstract

To provide support for preclinical research and development of therapeutic phage products that target mycobacteria. Within this scope, special emphasis is placed on preclinical development of NTM infections; and including antibiotic-resistant mycobacterial infections.

Key facts

NIH application ID: 11203283
Project number: 75N93024C00060-0-9999-1
Recipient: CFD RESEARCH CORPORATION
Principal Investigator: KETAN BHATT
Activity code: N43
Funding institute: NIH
Fiscal year: 2024
Award amount: $297,740
Award type: —
Project period: 2024-09-10 → 2025-09-09